All Stories

  1. AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest
  2. An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress
  3. Aurora B in cancer
  4. PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
  5. Activation of the endomitotic spindle assembly checkpoint and thrombocytopenia in Plk1-deficient mice
  6. An Atypical Oncogene Within the Atypical E2Fs
  7. A Cdh1-APC/FMRP Ubiquitin Signaling Link Drives mGluR-Dependent Synaptic Plasticity in the Mammalian Brain
  8. Casein Kinase 1δ Is an APC/CCdh1 Substrate that Regulates Cerebellar Granule Cell Neurogenesis
  9. Functional Reprogramming of Polyploidization in Megakaryocytes
  10. Cyclin C surprises in tumour suppression
  11. Splicing together sister chromatids
  12. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia
  13. A centrosomal route for cancer genome instability
  14. Preparing a cell for nuclear envelope breakdown: Spatio-temporal control of phosphorylation during mitotic entry
  15. APCCdc20 Suppresses Apoptosis through Targeting Bim for Ubiquitination and Destruction
  16. Dependency of the Spindle Assembly Checkpoint on Cdk1 Renders the Anaphase Transition Irreversible
  17. A Synthetic Lethal Interaction between APC/C and Topoisomerase Poisons Uncovered by Proteomic Screens
  18. Cyclin-dependent kinases
  19. The Greatwall–PP2A Axis in Cell Cycle Control
  20. The functional relevance of polyploidization in the skin
  21. The APC/C cofactor Cdh1 prevents replicative stress and p53-dependent cell death in neural progenitors
  22. Correction to Low Dose of Amino-Modified Nanoparticles Induces Cell Cycle Arrest
  23. Low Dose of Amino-Modified Nanoparticles Induces Cell Cycle Arrest
  24. microRNA-203: Tumor Suppression and Beyond
  25. The Aurora B Kinase and the Polycomb Protein Ring1B Combine to Regulate Active Promoters in Quiescent Lymphocytes
  26. Mitosis-targeting therapies: a troubleshooting guide
  27. A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis
  28. Robust mitotic entry is ensured by a latching switch
  29. miRNAs and cancer: An epigenetics view
  30. Aurora B prevents delayed DNA replication and premature mitotic exit by repressing p21Cip1
  31. Mitotic Kinases
  32. Cyclins and Cyclin-dependent Kinases
  33. The E3 ligase APC/C-Cdh1 is required for associative fear memory and long-term potentiation in the amygdala of adult mice
  34. HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
  35. Inhibiting Cell Cycle Kinases in Cancer Therapy
  36. Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2
  37. Cell Cycle-Based Therapies Move Forward
  38. Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells
  39. miRNAs versus oncogenes: the power of social networking
  40. Tpx2 Controls Spindle Integrity, Genome Stability, and Tumor Development
  41. Killing cells by targeting mitosis
  42. Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription
  43. Cdh1 Regulates Osteoblast Function through an APC/C-Independent Modulation of Smurf1
  44. Tumor suppression by Spinophilin
  45. Non-mitotic functions of the Anaphase-Promoting Complex
  46. From Plk1 to Plk5
  47. Physiological Relevance of Cell Cycle Kinases
  48. Oncogene-Induced Mitotic Stress: p53 and pRb Get Mad Too
  49. The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway
  50. MicroRNAs and the cell cycle
  51. Targeting Aneuploidy for Cancer Therapy
  52. Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner
  53. Crystal structure of the open conformation of the mammalian chaperonin CCT in complex with tubulin
  54. Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
  55. RINGO C is required to sustain the spindle-assembly checkpoint
  56. RINGO C is required to sustain the spindle-assembly checkpoint
  57. The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functions
  58. Cyclin-dependent kinases: a family portrait
  59. A GRFa2/Prop1/Stem (GPS) Cell Niche in the Pituitary
  60. Cell cycle, CDKs and cancer: a changing paradigm
  61. E2F2 represses cell cycle regulators to maintain quiescence
  62. Cell cycle control of pituitary development and disease
  63. Control of cell proliferation pathways by microRNAs
  64. Emerging cancer therapeutic opportunities by inhibiting mitotic kinases
  65. Genomic stability and tumour suppression by the APC/C cofactor Cdh1
  66. Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
  67. Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
  68. CDK inhibitors in cancer therapy: what is next?
  69. Cdk1 is sufficient to drive the mammalian cell cycle
  70. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression
  71. Targeting Cell Cycle Kinases for Cancer Therapy
  72. Mice thrive without Cdk4 and Cdk2
  73. Cell cycle kinases in cancer
  74. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients
  75. Cannabinoid receptors as novel targets for the treatment of melanoma
  76. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
  77. Mouse Models to Study the In Vivo Function of Cyclin-Dependent Kinases in Normal Homeostasis and Tumor Development
  78. Involvement of the pRb pathway in UVR-induced melanoma
  79. Rapid Growth of Invasive Metastatic Melanoma in Carcinogen-Treated Hepatocyte Growth Factor/Scatter Factor-Transgenic Mice Carrying an Oncogenic CDK4 Mutation
  80. Therapeutic opportunities to control tumor cell cycles
  81. Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin
  82. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication
  83. Is Cyclin D1-CDK4 kinase a bona fide cancer target?
  84. Preclinical Models for Cell Cycle-Targeted Therapies
  85. Mammalian cyclin-dependent kinases
  86. Cdk4 promotes adipogenesis through PPARγ activation
  87. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1
  88. Revisiting the “Cdk-Centric” View of the Mammalian Cell Cycle
  89. The European dimension for the mouse genome mutagenesis program
  90. Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6
  91. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15Ink4b-deficient mice
  92. RAS oncogenes: The first 30 years
  93. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
  94. Genetic rescue of Cdk4 null mice restores pancreatic β-cell proliferation but not homeostatic cell number
  95. Timeline: RAS oncogenes: the first 30 years
  96. Driving the Cell Cycle to Cancer
  97. Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
  98. Cyclin D-dependent kinases, INK4 inhibitors and cancer
  99. MILESTONES IN CELL DIVISION TO CYCLE OR NOT TO CYCLE: A CRITICAL DECISION IN CANCER
  100. Invasive melanoma in Cdk4-targeted mice
  101. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways
  102. Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas
  103. Genetic Analysis of Mammalian Cyclin-Dependent Kinases and Their Inhibitors
  104. Targeted Gene Transfer System Using a Streptavidin-Transforming Growth Factor-alpha Chimeric Protein
  105. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas
  106. Hypermethylation of the cell cycle inhibitor p15INK4b 3′-untranslated region interferes with its transcriptional regulation in primary lymphomas
  107. An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15 INK4b and p16 INK4a tumor suppressor genes
  108. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas
  109. Molecular control mechanisms of lysine and threonine biosynthesis in amino acid-producing corynebacteria: Redirecting carbon flow
  110. Molecular control mechanisms of lysine and threonine biosynthesis in amino acid-producing corynebacteria: Redirecting carbon flow
  111. The galE gene encoding the UDP-galactose 4-epimerase of Brevibacterium lactofermentum is coupled transcriptionally to the dmdR gene
  112. Directed mutagenesis of a regulatory palindromic sequence upstream from the Brevibacterium lactofermentum tryptophan operon
  113. Codon preference in Corynebacteria
  114. Analysis of the codon usage of the cephamycin C producer Nocardia lactamdurans
  115. The bleomycin resistance gene of transposon Tn5 is an excellent marker for transformation of corynebacteria
  116. Nucleotide sequence of the threonine synthase ( thrC ) gene of Brevibacterium lactofermentum